Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/REGENERON-PHARMACEUTICALS-10649/news/Regeneron-Pharmaceuticals-Announces-Phase-2-Study-of-Aflibercept-Co-Formulated-with-Rinucumab-ant-23142930/?utm_source=whatsapp&utm_medium=social&utm_campaign=share